An allosteric inhibitor of the Zika virus NS2B-NS3 protease with oral efficacy in mouse models
Jesus M. Ontoria(IRBM Science Park), Giacomo Paonessa(Fondazione Roma), Chantal Paolini(Istituto Superiore di Sanità), Laura Orsatti(IRBM Science Park), Alessandra Corio(IRBM Science Park), Carlo Toniatti(The University of Texas MD Anderson Cancer Center), Esther Torrente(IRBM Science Park), Cristina Alli, Antonino Missineo(IRBM Science Park), Jérôme Amaudrut(IRBM Science Park), Vincenzo Pucci(IRBM Science Park), Federica Ferrigno(IRBM Science Park), Giulia Proto(IRBM Science Park), Elisa Beghetto(IRBM Science Park), Romano Di Fabio(Vita-Salute San Raffaele University), Christian Montalbetti(IRBM Science Park), Maria Vittoria Orsale(IRBM Science Park), Monica Bisbocci(IRBM Science Park), Rita Graziani(IRBM Science Park), Maria Veneziano(IRBM Science Park), Silvana Vasile(Uppsala University), Nadine Alaimo(IRBM Science Park), Alberto Bresciani(University of Bergamo), Giovanni Ievoli(IRBM Science Park), Fabrizio Colaceci(IRBM Science Park), Leda Bencheva(Siena Biotech (Italy)), Silvia Conti(IRBM Science Park), Antonio Quotadamo(IRBM Science Park), Licia Tomei(IRBM Science Park), Martina Nibbio(IRBM Science Park)
Cited by 3
Related Papers
Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
|Science Signaling|2017|307
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
|Cancer Research|2015|275
Isolation of human glucose-6-pbosphate debydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5' non-coding region
|Nucleic Acids Research|1986|246
Structural analysis of the X‐linked gene encoding human glucose 6‐phosphate dehydrogenase.
|The EMBO Journal|1986|229
GPCRmd uncovers the dynamics of the 3D-GPCRome
|Nature Methods|2020|199